: $Actelis Networks(ASNS)$ 中概退潮,玩你们俩兄弟够了,神经病一样的庄,疯狂的手法查看全文
usbiostock2018-06-28 19:46
$Arsanis, Inc.(ASNS)$ 公司宣布ASN100预防金黄色葡萄球菌肺炎临床2期试验未能达到主要终点,公司将终止该药的研发。公司重点将放在ASN500,用于预防呼吸道合胞病毒感染。查看全文
美股医药Z博士2017-12-12 11:33
$Arsanis, Inc.(ASNS)$ 来推荐一只IPO不久的股票,喜欢短线的朋友可以关注。公司具有很多极具潜力的单抗抗生素药物,目前股价已跌破发行价。今日两大投行提高它的评级,并给出23的目标价,结果有意思的是股价居然-12%。是个不错的短线机会,第一个目标价16左右。查看全文
$Arsanis, Inc.(ASNS)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-10-10 AccNo: 0000315066-18-002426 Size: 7 KB 网页链接
$Arsanis, Inc.(ASNS)$ CT ORDER - Confidential treatment order Filed: 2018-08-27 AccNo: 9999999997-18-007490 Size: 17 KB 网页链接
$Arsanis, Inc.(ASNS)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-08-13 AccNo: 0001564590-18-021372 Size: 8 MB 网页链接
$Arsanis, Inc.(ASNS)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-08-13 AccNo: 0001564590-18-021372 Size: 8 MB 网页链接
$Arsanis, Inc.(ASNS)$ 8-K - Current report Filed: 2018-08-13 AccNo: 0001564590-18-021370 Size: 281 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Arsanis, Inc.(ASNS)$ 8-K - Current report Filed: 2018-08-13 AccNo: 0001564590-18-021370 Size: 281 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Arsanis, Inc.(ASNS)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-08-10 AccNo: 0000315066-18-002170 Size: 8 KB 网页链接
$Arsanis, Inc.(ASNS)$ 8-K - Current report Filed: 2018-06-28 AccNo: 0001193125-18-206538 Size: 37 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Arsanis, Inc.(ASNS)$ 8-K - Current report Filed: 2018-06-12 AccNo: 0001193125-18-190522 Size: 2 MBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Arsanis, Inc.(ASNS)$ 8-K - Current report Filed: 2018-06-07 AccNo: 0001193125-18-186853 Size: 18 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接